Latest News in the pharma Industry

Research & Development

BMS adds lead TGF-beta asset to portfolio through acquisition

25 Aug 2020

Forbius's lead investigational asset, AVID200 holds promise as an effective and well-tolerated therapeutic in fibrotic diseases and immuno-oncology.

Catalent expands manufacturing support for COVID-19 vaccine AZD1222

24 Aug 2020

The company will prepare the Harmans facility to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing later this year.

CRO Europital opens new UK site in response to urgent demand

24 Aug 2020

The company will target working with small and medium biotechs who require a science-driven, rather than a volume-driven partner.

J&J agrees in principle to supply UK with its COVID-19 vaccine candidate

18 Aug 2020

Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators.

Sai Life Sciences opens new Research & Technology Centre in Hyderabad

17 Aug 2020

One of India's fastest growing CDMOs goes "beyond the norm" to reinvent itself as a new generation global CDMO.

Sanofi galvanizes strategic product pipeline with Principia Biopharma acquisition

17 Aug 2020

The transaction will enable Sanofi to expand and accelerate development of BTK inhibitors across multiple indications, including MS and other central nervous system diseases.

First investment for Colorcon Ventures in AI drug discovery leader

13 Aug 2020

Atomwise technology removes the barriers of physical screening that have limited the success of traditional methods for small molecule drug discovery.

Samsung Biologics adds fourth plant due to growing demand

11 Aug 2020

Plant 4 will add 256 KL capacity to its site, which is scheduled to commence manufacturing activities in the second half of 2022.

Moderna inks US deal for 100 million doses of its COVID vaccine

11 Aug 2020

The company is also scaling up its manufacturing capability with its partners — Lonza, Catalent and Rovi — should the vaccine get the green light.

Colorcon opens in Australia to meet growing demand from local pharma industry

4 Aug 2020

Customers in the region will have the opportunity to conduct laboratory-scale compression and coating trials, using automated coating equipment.

Oxford Biomedica signs 3-year CSA for Parkinson’s disease gene therapy program

3 Aug 2020

The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities.

Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate